Iovance Biotherapeutics
IOVA
1,46 €
Share price
1.78%
Change (1 day)
-80.54%
Change (1 year)
Categories
Iovance Biotherapeutics (IOVA) - Total debt
Total debt on the balance sheet as of March 2025 : €45.63 Million
According to Iovance Biotherapeutics 's latest financial reports the company's total debt is €45.63 Million. A company’s total debt is the sum of all current and non-current debts.
Iovance Biotherapeutics - Total debt on balance sheet (from 2011 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | €55.98 M | -18.42% |
| 2023-12-31 | €68.62 M | -13.85% |
| 2022-12-31 | €79.65 M | 26.12% |
| 2021-12-31 | €63.16 M | 50.39% |
| 2020-12-31 | €41.99 M | 309.12% |
| 2019-12-31 | €10.26 M | |
| 2018-12-31 | N/A | |
| 2012-12-31 | €4.89 M | 27.26% |
| 2011-12-31 | €3.85 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 NRC Health
NRC | €55.39 M | 21.38% | 🇺🇸 USA |
 Nymox Pharmaceutical NYMX | €0.68 M | -98.50% | Bahamas |